Patents by Inventor Nicola Beaucamp

Nicola Beaucamp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240327890
    Abstract: The present invention relates to methods for selecting between conditions which enhance cell growth or biomass generation and conditions which affect the N-glycosylation maturity of expressed glycoprotein produced by eukaryotic cells under fermentation culture conditions. Thus, in the methods of the present invention, the glycoprotein producing cells are cultured in a medium which is tailored to a desired end result. The invention also embraces the medium and the use thereof.
    Type: Application
    Filed: June 12, 2024
    Publication date: October 3, 2024
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Oliver POPP, Nicola BEAUCAMP, Georg DRABNER, Stephanie ESSLINGER
  • Patent number: 12084192
    Abstract: A device is for assisting the piloting in acceleration of an aircraft in taking in order to control its speed. The comprises a control member, adapted to be actuated by a pilot from a neutral position to define a taxiing piloting command for controlling the speed of the aircraft and a central controller, adapted to operate pilot at least one engine of the aircraft to apply the taxiing command defined by the pilot. The taxiing piloting command is an acceleration or deceleration command of the aircraft during taxiing.
    Type: Grant
    Filed: July 25, 2022
    Date of Patent: September 10, 2024
    Assignee: DASSAULT AVIATION
    Inventors: Angélique Beaucamp, Laurent Fillet, Nicolas Le Corre
  • Publication number: 20210222220
    Abstract: The present invention relates to methods for selecting between conditions which enhance cell growth or biomass generation and conditions which affect the N-glycosylation maturity of expressed glycoprotein produced by eukaryotic cells under fermentation culture conditions. Thus, in the methods of the present invention, the glycoprotein producing cells are cultured in a medium which is tailored to a desired end result. The invention also embraces the medium and the use thereof.
    Type: Application
    Filed: August 28, 2020
    Publication date: July 22, 2021
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Oliver POPP, Nicola BEAUCAMP, Georg DRABNER, Stephanie ESSLINGER
  • Publication number: 20170058309
    Abstract: The present invention relates to methods for selecting between conditions which enhance cell growth or biomass generation and conditions which affect the N-glycosylation maturity of expressed glycoprotein produced by eukaryotic cells under fermentation culture conditions. Thus, in the methods of the present invention, the glycoprotein producing cells are cultured in a medium which is tailored to a desired end result. The invention also embraces the medium and the use thereof.
    Type: Application
    Filed: August 12, 2016
    Publication date: March 2, 2017
    Applicant: Hoffmann-La Roche Inc.
    Inventors: OLIVER POPP, NICOLA BEAUCAMP, GEORG DRABNER, STEPHANIE ESSLINGER
  • Patent number: 8257728
    Abstract: The present invention relates to a method for producing a device comprising the steps of (a) providing a solution comprising dissolved osteoinductive protein, (b) contacting the solution of the preceding step with a carrier containing a surface of metal or a metal alloy, (c) allowing coating of the surface of said carrier with said dissolved protein and (d) drying of the coated carrier obtained in step (c) wherein steps (b) to (d) are carried out under a reduced concentration of oxygen. The invention also encompasses a device obtainable by the method of the present invention. Moreover, the present invention relates to a pharmaceutical composition comprising the said device and to the use of the device for the preparation of a pharmaceutical composition to be used for an accelerated osseointegration and new bone formation. Finally, the present invention relates to a kit comprising the device of the present invention.
    Type: Grant
    Filed: May 28, 2010
    Date of Patent: September 4, 2012
    Assignee: Scil Technology GmbH
    Inventors: Klaus Hellerbrand, Nicola Beaucamp, Ulrich Kohnert
  • Publication number: 20110020658
    Abstract: The present invention relates to a method for producing a device comprising the steps of (a) providing a solution comprising dissolved osteoinductive protein, (b) contacting the solution of the preceding step with a carrier containing a surface of metal or a metal alloy, (c) allowing coating of the surface of said carrier with said dissolved protein and (d) drying of the coated carrier obtained in step (c) wherein steps (b) to (d) are carried out under a reduced concentration of oxygen. The invention also encompasses a device obtainable by the method of the present invention. Moreover, the present invention relates to a pharmaceutical composition comprising the said device and to the use of the device for the preparation of a pharmaceutical composition to be used for an accelerated osseointegration and new bone formation. Finally, the present invention relates to a kit comprising the device of the present invention.
    Type: Application
    Filed: May 28, 2010
    Publication date: January 27, 2011
    Applicant: SCIL TECHNOLOGY GMBH
    Inventors: Klaus Hellerbrand, Nicola Beaucamp, Ulrich Kohnert
  • Patent number: 7763270
    Abstract: The present invention relates to a method for producing a device comprising the steps of (a) providing a solution comprising dissolved osteoinductive protein, (b) contacting the solution of the preceding step with a carrier containing a surface of metal or a metal alloy, (c) allowing coating of the surface of said carrier with said dissolved protein and (d) drying of the coated carrier obtained in step (c) wherein steps (b) to (d) are carried out under a reduced concentration of oxygen. The invention also encompasses a device obtainable by the method of the present invention. Moreover, the present invention relates to a pharmaceutical composition comprising the said device and to the use of the device for the preparation of a pharmaceutical composition to be used for an accelerated osseointegration and new bone formation. Finally, the present invention relates to a kit comprising the device of the present invention.
    Type: Grant
    Filed: July 9, 2003
    Date of Patent: July 27, 2010
    Assignee: Scil Technology GmbH
    Inventors: Klaus Hellerbrand, Nicola Beaucamp, Ulrich Kohnert
  • Publication number: 20060240062
    Abstract: The present invention relates to a method for producing a device comprising the steps of (a) providing a solution comprising dissolved osteoinductive protein, (b) contacting the solution of the preceding step with a carrier containing a surface of metal or a metal alloy, (c) allowing coating of the surface of said carrier with said dissolved protein and (d) drying of the coated carrier obtained in step (c) wherein steps (b) to (d) are carried out under a reduced concentration of oxygen. The invention also encompasses a device obtainable by the method of the present invention. Moreover, the present invention relates to a pharmaceutical composition comprising the said device and to the use of the device for the preparation of a pharmaceutical composition to be used for an accelerated osseointegration and new bone formation. Finally, the present invention relates to a kit comprising the device of the present invention.
    Type: Application
    Filed: July 9, 2003
    Publication date: October 26, 2006
    Inventors: Klaus Hellerbrand, Nicola Beaucamp, Ulrich Kohnert